Wouters EF - Search Results

1

Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease.

Mercken EM, Hageman GJ, Schols AM, Akkermans MA, Bast A, Wouters EF. Mercken EM, et al. Among authors: wouters ef. Am J Respir Crit Care Med. 2005 Oct 15;172(8):994-1001. doi: 10.1164/rccm.200411-1580OC. Epub 2005 Jul 22. Am J Respir Crit Care Med. 2005. PMID: 16040783

2

Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology.

Vernooy JH, Dentener MA, van Suylen RJ, Buurman WA, Wouters EF. Vernooy JH, et al. Among authors: wouters ef. Am J Respir Cell Mol Biol. 2002 Jan;26(1):152-9. doi: 10.1165/ajrcmb.26.1.4652. Am J Respir Cell Mol Biol. 2002. PMID: 11751215

3

Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease.

Gosker HR, Engelen MP, van Mameren H, van Dijk PJ, van der Vusse GJ, Wouters EF, Schols AM. Gosker HR, et al. Among authors: wouters ef. Am J Clin Nutr. 2002 Jul;76(1):113-9. doi: 10.1093/ajcn/76.1.113. Am J Clin Nutr. 2002. PMID: 12081824

4

Decreased redox state in red blood cells from patients with sarcoidosis.

Rothkrantz-Kos S, Drent M, Vuil H, De Boer M, Bast A, Wouters EF, Roos D, van Dieijen-Visser MP. Rothkrantz-Kos S, et al. Among authors: wouters ef. Sarcoidosis Vasc Diffuse Lung Dis. 2002 Jun;19(2):114-20. Sarcoidosis Vasc Diffuse Lung Dis. 2002. PMID: 12102606

5

Body mass index modulates aromatic DNA adduct levels and their persistence in smokers.

Godschalk RW, Feldker DE, Borm PJ, Wouters EF, van Schooten FJ. Godschalk RW, et al. Among authors: wouters ef. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):790-3. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12163336

6

Tumor necrosis factor-alpha inhibits myogenesis through redox-dependent and -independent pathways.

Langen RC, Schols AM, Kelders MC, Van Der Velden JL, Wouters EF, Janssen-Heininger YM. Langen RC, et al. Among authors: wouters ef. Am J Physiol Cell Physiol. 2002 Sep;283(3):C714-21. doi: 10.1152/ajpcell.00418.2001. Am J Physiol Cell Physiol. 2002. PMID: 12176728

7

Arm mechanical efficiency and arm exercise capacity are relatively preserved in chronic obstructive pulmonary disease.

Franssen FM, Wouters EF, Baarends EM, Akkermans MA, Schols AM. Franssen FM, et al. Among authors: wouters ef. Med Sci Sports Exerc. 2002 Oct;34(10):1570-6. doi: 10.1097/00005768-200210000-00007. Med Sci Sports Exerc. 2002. PMID: 12370557

8

Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.

Vernooy JH, Küçükaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, Wouters EF. Vernooy JH, et al. Among authors: wouters ef. Am J Respir Crit Care Med. 2002 Nov 1;166(9):1218-24. doi: 10.1164/rccm.2202023. Am J Respir Crit Care Med. 2002. PMID: 12403691

9

Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease.

Küçükaycan M, Van Krugten M, Pennings HJ, Huizinga TW, Buurman WA, Dentener MA, Wouters EF. Küçükaycan M, et al. Among authors: wouters ef. Respir Res. 2002;3(1):29. doi: 10.1186/rr194. Epub 2002 Nov 29. Respir Res. 2002. PMID: 12537602 Free PMC article.

10

Early clinical investigation of Viozan (sibenadet HCl), a novel D2 dopamine receptor, beta2-adrenoceptor agonist for the treatment of chronic obstructive pulmonary disease symptoms.

Ind PW, Laitinen L, Laursen L, Wenzel S, Wouters E, Deamer L, Nystrom P. Ind PW, et al. Respir Med. 2003 Jan;97 Suppl A:S9-21. Respir Med. 2003. PMID: 12564607 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results